Smart Pills
Healthcare News World

Smart Pills market is anticipated to attain growth owing to its diagnostic Imaging and drug delivery application for gastrointestinal diseases.

Smart pills are a form of pharmaceutical capsules that contains miniature electronic sensors to perform function such as drug delivery, sensing and imaging. The electronic sensors helps in providing messages about the inside body environments to the devices such as mobile and patches. The sensors included in the pills are bio sensors or chemical sensors. On intake of capsule, it passes through the gastrointestinal tract and thereby, captures all the information within the system. Theses smart pills or capsules provide essential information with easy process and thus is classified as distinct futuristic ingestible sensors.

Global smart pills market is poised to grow at a CAGR of XX% over the forecasted period (2019 – 2026).

Emergence of smart pills has provided a revolutionary introduction to the medical treatment. The capsules acts as a source to provide sensitive information related stomach, intestines, esophagus and many more. Introduction of the FDA approved smart pill was used in November, 2017, for the treatment of schizophrenia, depression and bipolar disorder patients. On introduction of the smart pills, prophesized an improvement from the consistent medication process among the group of patients. Further, it is anticipated a remarkable opportunity in demand of smart pills in future. Hence, the technology will enable doctors to only track drug compliance but also will increase patient adherence.

Increase in gastrointestinal disease and application of smart pill

Gastrointestinal diseases include intestinal disease, gastric disease, oesophageal disease and accessory digestive gland disease. Based on the data from the Centers for Disease Control and Prevention, National Cancer Institute, it is witnessed that more than 7 million of gastrointestinal reflux were diagnosed in the ambulatory care during the year 2012. Further, the rate of disease tends to increase over the course. Hence, to relive and provide comfort, oral, liquid and other therapies are prescribed. Yet, a relevant treatment process becomes hard enough to prescribe by the doctors unless various imaging and diagnostic tests are done. Introduction of smart pills and its application has enthralled a new potential in reducing clinical and other tests with an optimum price. Hence, it offers an opportunity to replace traditional endoscopy diagnostic techniques. As the pill can easily manoeuvre to capture multidimensional images and help in identification and preparation of treatment procedures. In a similar context, FDA cleared smart pill “PillCam Colon” by Medtronic offers an alternative solution to the patient treatment that refuse colon exams. On intake of pill, it offers quality visons of the colon and thus prospects a future in the treatment of colorectal cancer.

The competitive landscape of the global Smart Pills market consists of global players. Some of the players in the market include Johnson & Johnson (DePuy Synthes), Medtronic, Stryker, Zimmer Biomet, Globus Medical, Orthofix Holdings, Inc, RTI Surgical Holdings, Inc, K2M In., Kuros Biosciences, NuVasive, Inc., Arthrex, Inc., and Xtant Medical. amongst others.

Key Segments

Smart Pills Targeted Area, Overview, 2019 – 2026 (USD Million)

  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine
  • Others

Smart Pills Application, Overview, 2019 – 2026 (USD Million)

  • Capsule Endoscopy
  • Patient Monitoring
  • Drug Delivery

Regional Outlook, 2019 – 2026 (USD Million)

  • North America
    • North America Proteomics, By Targeted Area
    • North America Proteomics, By Application
    • North America Proteomics, By Countries
      • U.S.
        • U.S. Proteomics, By Targeted Area
        • U.S. Proteomics, By Application
      • Canada
        • Canada Proteomics, By Targeted Area
        • Canada Proteomics, By Application
  • Europe
    • Europe Proteomics, By Targeted Area
    • Europe. Proteomics, By Application
    • Europe Proteomics, By Countries
      • Germany
        • Germany Proteomics, By Targeted Area
        • Germany Proteomics, By Application
      • United Kingdom
        • United Kingdom Proteomics, By Targeted Area
        • United Kingdom Proteomics, By Application
      • France
        • France Proteomics, By Targeted Area
        • France Proteomics, By Application
      • Italy
        • Italy Proteomics, By Targeted Area
        • Italy Proteomics, By Application
      • Spain
        • Spain Proteomics, By Targeted Area
        • Spain Proteomics, By Application
      • Russia
        • Russia Proteomics, By Targeted Area
        • Russia Proteomics, By Application
      • Benelux Union
        • Benelux Union Proteomics, By Targeted Area
        • Benelux union Proteomics, By Application
      • Rest of Europe
        • Rest of Europe Proteomics, By Targeted Area
        • Rest of Europe Proteomics, By Application
  • Asia Pacific
    • Asia Pacific Proteomics, By Targeted Area
    • Asia Pacific Proteomics, By Application
    • Asia Pacific Proteomics, By Countries
      • China
        • China Proteomics, By Targeted Area
        • China Proteomics, By Application
      • Japan
        • Japan Proteomics, By Targeted Area
        • Japan Proteomics, By Application
      • India
        • India Proteomics, By Targeted Area
        • India Proteomics, By Application
      • South Korea
        • South Korea Proteomics, By Targeted Area
        • South Korea Proteomics, By Application
      • Australia
        • Australia Proteomics, By Targeted Area
        • Australia Proteomics, By Application
      • South East Asia
        • South East Asia Proteomics, By Targeted Area
        • South East Asia Proteomics, By Application
        • South East Asia Proteomics, By Countries
          • Indonesia
          • Thailand
          • Philippines
          • Malaysia
          • Rest of South East Asia
      • Rest of Asia-Pacific
        • Rest of Asia Pacific Proteomics, By Targeted Area
        • Rest of Asia Pacific Proteomics, By Application
  • Latin America
    • Latin America Proteomics, By Targeted Area
    • Latin America Proteomics, By Application
    • Latin America Proteomics, By Countries
      • Brazil
        • Brazil Proteomics, By Targeted Area
        • Brazil Proteomics, By Application
      • Mexico
        • Mexico Proteomics, By Targeted Area
        • Mexico Proteomics, By Application
      • Rest of Latin America
        • Rest of Latin America Proteomics, By Targeted Area
        • Rest of Latin America Proteomics, By Application
  • Middle East & Africa
    • Middle East & Africa Proteomics, By Targeted Area
    • Middle East & Africa Proteomics, By Application
    • Middle East & Africa Proteomics, By Countries
      • GCC Countries
        • GCC Countries Proteomics, By Targeted Area
        • GCC Countries Proteomics, By Application
      • South Africa
        • South Africa Proteomics, By Targeted Area
        • South Africa Proteomics, By Application
      • Turkey
        • Turkey Proteomics, By Targeted Area
        • Turkey Proteomics, By Application
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Proteomics, By Targeted Area
        • Rest of Middle East & Africa Proteomics, By Application

Prominent Players analysed in the market include

  • BDD Limited.
  • Boston Scientific Corporation 
  • CapsoVision, Inc.
  • Cerner Corporation
  • Check-Cap
  • Ge Healthcare
  • JINSHAN Science & Technology
  • Medtronic       
  • Olympus America      
  • Proteus Digital Health, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *